29 results found.

Peripheral Arterial Disease Clinical Trial using Iloprost (Ilomedin, BAYQ6256)

Bayer - Recruiting 18 years or older.
- Iloprost Therapy in Patients With Critical Limb Ischemia: Evaluation of Efficacy and Safety.
Iloprost (Ilomedin, BAYQ6256)

Critical Limb Ischemia, or Peripheral Artery Disease Clinical Trial using PTA + Infusion of MSC_Apceth; PTA

Apceth GmbH & Co. KG - Recruiting 40 years to 80 years.
- Open, Randomized, Mono-Centre, Two-Parallel Group Clinical Phase I/II Trial on the Evaluation of Tolerability and Efficacy of an Intravenous Infusion of Human Bone Marrow Derived Autologous, CD34-Negative Mesenchymal Stem Cells for the Treatment of Critical Limb Ischemia in Patients With Advanced Peripheral Arterial Occlusive Disease Subsequent to Percutaneous Transluminal Angioplasty.
PTA + Infusion of MSC_Apceth; PTA

Critical Limb Ischemia, Peripheral Arterial Disease, or Periphera Clinical Trial using Bone marrow concentration device; Placebo procedure (sham)

Biomet, Inc. - Recruiting 21 years or older.
- MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD).
Bone marrow concentration device; Placebo procedure (sham)

Peripheral Artery Disease, or Hypertension Clinical Trial using nebivolol; Metoprolol succinate

Thomas Jefferson University - Recruiting 18 years or older.
- Effect of Nebivolol Compared With Metoprolol in Hypertensive Patients With Peripheral Arterial Disease.
nebivolol; Metoprolol succinate

Peripheral Artery Disease Clinical Trial using measuring the ankle brachial index

University of Erlangen-Nrnberg Medical School - Recruiting 18 years or older.
- Prevalence of Peripheral Arterial Disease in Acute Ischemic and Hemorrhagic Stroke Patients.
measuring the ankle brachial index

Peripheral Arterial Disease Clinical Trial using Shockwave Lithoplasty System

Shockwave Medical, Inc. - Recruiting 18 years or older.
- Safety and Performance Study of the Shockwave Lithoplasty System.
Shockwave Lithoplasty System

Peripheral Arterial Disease Clinical Trial using IN.PACT AdmiralT Drug Eluting Balloon

Medtronic Endovascular - Recruiting 18 years or older.
- The IN.PACT Global Clinical Study for the Treatment of Comprehensive Superficial Femoral and/or Popliteal Artery Lesions Using the IN.PACT AdmiralT Drug-Eluting Balloon..
IN.PACT AdmiralT Drug Eluting Balloon

Peripheral Arterial Disease, or Claudication Clinical Trial using CVI Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter; Bare Percutaneous Transluminal Angioplasty Balloon Catheter

Covidien - Recruiting 18 years or older.
- Prospective, Randomized, Multi-center, Single-blinded Study for the Treatment of Subjects Presenting With De Novo Occluded/Stenotic or Re-occluded/Restenotic Lesions of the Superficial Femoral or Popliteal Arteries Using Paclitaxel or Bare Percutaneous Transluminal Angioplasty Balloon Catheter.
CVI Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter; Bare Percutaneous Transluminal Angioplasty Balloon Catheter

Peripheral Arterial Disease, or Intermittent Claudication Clinical Trial using Zibotentan (ZD4054); placebo

University of Virginia - Recruiting 40 years or older.
- A Phase II Clinical Trail to Assess the Safety and Effects of ZD4054 (Zibotentan) on Exercise Induced Calf Muscle Perfusion in Patients With Intermittent Claudication (Rutherford II or III)..
Zibotentan (ZD4054); placebo

Peripheral Arterial Disease Clinical Trial using Motivational Interviewing; PACE

University of Kansas - Recruiting N/A or older.
- Promoting Walking in African Americans With Peripheral Arterial Disease.
Motivational Interviewing; PACE

Lower-extremity Peripheral Arterial Disease Clinical Trial

Terumo Europe N.V. - Recruiting 18 years or older.
- Prospective, Non-randomized, Multicentre, Observational Registry to Assess Clinically Relevant Benefit of Performing the Whole PTA Procedure Using the Rapid Exchange (RX) Devices..

Peripheral Arterial Disease, or Cardiovascular Disease Clinical Trial

University of California, San Francisco - Recruiting 22 years to 89 years.
- Endothelial Function and Vein Graft Remodeling.

Peripheral Arterial Disease Clinical Trial using Administration of dexamethasone to SFA/popliteal adventitia

University of California, San Francisco - Recruiting 40 years to 80 years.
- Dexamethasone Infusion to the Adventitia to Enhance Clinical Efficacy After Femoropopliteal Revascularization.
Administration of dexamethasone to SFA/popliteal adventitia

Peripheral Arterial Disease, or Peripheral Vascular Disease Clinical Trial using HAVG graft implantation

Humacyte, Inc. - Recruiting 18 years to 80 years.
- A Pilot Study for Evaluation of the Safety and Efficacy of Humacyte's Human Acellular Vascular Graft as an Above-Knee Femoro-Popliteal Bypass Graft in Patients With Peripheral Arterial Disease.
HAVG graft implantation

Peripheral Arterial Disease Clinical Trial using edoxaban; Clopidogrel; Aspirin

Daiichi Sankyo Inc. - Recruiting 18 years or older.
- A Randomized, Open-Label, Parallel-Group, Multi-Center Study Of Adding Edoxaban Or Clopidogrel To Aspirin To Maintain Patency In Subjects With Peripheral Arterial Disease Following Femoropopliteal Endovascular Intervention.
edoxaban; Clopidogrel; Aspirin

Peripheral Arterial Disease Clinical Trial using Angioplasty with Zilver PTX; Best medical treatment; Zilver PTX

Rigshospitalet, Denmark - Recruiting 18 years or older.
- Paclitaxel Eluting Stent or Exercise for Thigh Atherosclerosis (PESETA).
Angioplasty with Zilver PTX; Best medical treatment; Zilver PTX

Peripheral Arterial Occlusive Disease Clinical Trial

Seoul National University Hospital - Recruiting 19 years to 80 years.
- Validation of the Korean Version of the Walking Impairment Questionnaire in Patients With Peripheral Arterial Disease.

Peripheral Arterial Disease Clinical Trial using Everolimus-Eluting Stent (PROMUS ELEMENT)

Flanders Medical Research Program - Recruiting 18 years or older.
- PREVENT: a Prospective, Multi-center, Monitored Trial Investigating the Implant of the Promus Everolimus-Eluting Stent System in Critically Ischemic Lesions BTK.
Everolimus-Eluting Stent (PROMUS ELEMENT)

Peripheral Arterial Disease Clinical Trial using NanoCross .014 balloon catheter

Flanders Medical Research Program - Recruiting 18 years or older.
- NanoCross BTK, a Prospective, Non-randomized, Multicenter, Controlled Trial Evaluating the Performance of the NanoCrossTM .014 Balloon Catheter in Infrapopliteal Lesions.
NanoCross .014 balloon catheter

Peripheral Arterial Disease Clinical Trial using Beetroot Juice (Beet-It Stamina Shot) & Supervised Exercise Training; Placebo Comparator Beverage (Beet-It Stamina Shot) & Exercise Training

Duke University - Recruiting 40 years to 85 years.
- Increased Plasma Nitrite, Tissue Oxygenation and Functional Changes in PAD.
Beetroot Juice (Beet-It Stamina Shot) & Supervised Exercise Training; Placebo Comparator Beverage (Beet-It Stamina Shot) & Exercise Training

Peripheral Arterial Disease Clinical Trial using percutaneous transluminal angioplasty balloon catheter

Acotec Scientific Co., Ltd - Recruiting 18 years to 80 years.
- A Prospective, Multicenter and Single-arm Target Value Clinical Study on the Efficacy and Safety of Peripheral Balloon Dilatation Catheter in PTA Procedure.
percutaneous transluminal angioplasty balloon catheter

Peripheral Arterial Disease Clinical Trial

be Medical - Recruiting 18 years or older.
- A Prospective Multicenter Registry to Evaluate Safety and Performance of REMEDY, Biodegradable Peripheral Stent for the Treatment of Occluded or Stenotic Superficial Femoral Arteries..

Intermittent Claudication, or Peripheral Vascular Diseases Clinical Trial using Treadmill Exercise Training; Arm Ergometry Exercise Training; Usual Care

University of Minnesota - Clinical and Translational Science Institute - Recruiting 18 years to 90 years.
- Exercise Training to Reduce Claudication: Arm Ergometry Versus Treadmill Walking.
Treadmill Exercise Training; Arm Ergometry Exercise Training; Usual Care

Peripheral Arterial Disease Clinical Trial using Patient education

Rennes University Hospital - Recruiting 18 years to 75 years.
- Optimized Supervised Education Program for Peripheral Arterial Disease: Ambulatory Management With Patient Education.
Patient education

Peripheral Arterial Disease Clinical Trial using Acetylsalicylic acid; Clopidogrel

University of Roma La Sapienza - Recruiting 40 years to 80 years.
- Tailored Strategy for Residual Platelet Activity In Advanced Peripheral Artery Disease: New Optimal Management..
Acetylsalicylic acid; Clopidogrel

Oxygen Consumption, Aortic Aneurysm, or Peripheral Arterial Disea Clinical Trial

NHS Lothian - Recruiting N/A or older.
- Study of Post-operative Oxygen Consumption Following Vascular Surgery.

Prevention, Screening, Abdominal Aortic Aneurysms, Peripheral Art Clinical Trial using Screening for hypertension, lower limb atherosclerosis and abdominal aortic aneurysm

Viborg Hospital - Recruiting 65 years to 74 years.
- Randomized Preventive Vascular Screening Trial of 65-74 Year Old Men in the Central Region of Denmark.
Screening for hypertension, lower limb atherosclerosis and abdominal aortic aneurysm

Peripheral Arterial Disease Clinical Trial using Cardiac Imaging + Treatment

UMC Utrecht - Recruiting 50 years or older.
- Non-Invasive Cardiac Screening in High Risk Patients -The GROUND Study.
Cardiac Imaging + Treatment

Peripheral Arterial Disease Clinical Trial using intraarterial and intramuscular injection of BMCs

Heinrich-Heine University, Duesseldorf - Recruiting N/A or older.
- Transplantation of Autologous Mononuclear Bone Marrow Stem Cells in Patients With Peripheral Arterial Disease (TAM-PAD Study).
intraarterial and intramuscular injection of BMCs